Anavex Life Sciences Corp (AVXL)

[Gator328]

No, Anavex gets the FDA rare disease priority review voucher if/when Rett is approved. It's Anavex's reward for spending the time to research a rare disease and it's supposed to incentivize companies to pursue diseases that may not be profitable to treat.

As time goes on and as these vouchers become worth less and less now that there's directive to speed up the approval process for all drugs, I can see a day in the distant future when the FDA needs to add more value to these vouchers. Perhaps a guaranteed re-submission if the drug isn't approved. Or maybe add priority review for BTD. Otherwise the incentive to research rare and tropical diseases will continue to be diminished and companies like Anavex will determine that it's better to hold them than sell them.